Pimozide

Pimozide has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 3, 2026: “Antipsychotic drug pimozide extends lifespan and boosts stress resistance in nematodes”.

InterventionApproved 1984

1 paper studies it2 more mention it5 findingsUpdated

PubChemChEBI

See all 3 papers on pimozide

At a glance

The findings reach mice, none yet in people. 3 independent labs in 2 countries; 7 trials, none about aging, 2 with no results posted.

None of its findings points the other way.

Worms or flies and mice: a single group. Cells and humans: nothing yet.
  • 3 independent labs in 2 countries
  • 7 trials, none about aging, 2 with no results posted
  • Funders: Hunan Normal University and others
  • Model organisms1

What did studies of pimozide find?

5

Studies of pimozide measured 5 outcomes, among them skn-1, locomotor function and lifespan.

skn-1

upin worms1

1 study
  1. Pimozide activates skn-1 in nematodes.

    “Mechanistically, pimozide promotes the nuclear localization of SKN-1”

    Model organismsin nematodes

    Antipsychotic drug pimozide extends lifespan and boosts stress resistance in nematodes

    Antioxidants (Basel, Switzerland)

More on skn-1

Locomotor function

upin worms1

1 study
  1. Pimozide improves locomotor function in pimozide-treated nematodes.

    “preserved locomotor function, and decreased paralysis incidence.”

    Model organismsin pimozide-treated nematodes

    Antipsychotic drug pimozide extends lifespan and boosts stress resistance in nematodes

    Antioxidants (Basel, Switzerland)

Lifespan

upin worms1+50% median lifespan

1 study
  1. Pimozide extends lifespan in worms (0.1 μM pimozide) (+50.0% median lifespan).

    “0.1 μM pimozide significantly extends nematode lifespan, increasing mean, median, and maximum lifespans by 44.3%, 50.0%, and 39.8%, respectively.”

    Model organisms0.1 μM pimozide0.1 μM

    Antipsychotic drug pimozide extends lifespan and boosts stress resistance in nematodes

    Antioxidants (Basel, Switzerland)

Neuroprotective effects of empagliflozin

downin rats1

1 study
  1. Pimozide impairs neuroprotective effects of empagliflozin in rats (post-cardiac arrest).

    “inhibition of ketone body oxidative metabolism by pimozide diminished the neuroprotective effects of empagliflozin following CA in rats.”

    Animalspost-cardiac arrestmales

    Empagliflozin Attenuates Global Cerebral Ischemic Injury After Cardiac Arrest Through Enhancing Ketone Body Oxidative Metabolism in Rats

    Journal of the American Heart Association

Hypoxia and HIF signaling

downin mice1

1 study
  1. Pimozide decreases hypoxia and HIF signaling in mice (dapagliflozin-elicited activation).

    “Administration of pimozide, which is a succinyl-CoA:3-ketoacid CoA transferase (SCOT) inhibitor that inhibits ketone body metabolism, abolished dapagliflozin-elicited activation of HIF-1α signaling.”

    Animalsdapagliflozin-elicited activation

    Sodium-glucose Co-transporter 2 (SGLT2) inhibitor dapagliflozin acutely activates cardiomyocyte HIF-1α signaling via succinate, a signaling metabolite

    Journal of pharmacological sciences

More on Hypoxia and HIF signaling

Has pimozide been tested in people?

0 of 7 about aging

7 trials are registered, but no study of it in people has been published yet.

Approved

In trials

All 11

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 2Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 03 papers in 12 months